CompletedNot Applicable

International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients

United States26 participantsStarted 2010-04

Plain-language summary

This study also aims to raise awareness among both patients and health-care providers about the importance of pre-travel health consultation and preventive interventions prior to international travel. Through appropriate health counseling, cancer patients will have less risk of having travel -related health complications and thus have a better quality of life and overall improved sense of wellbeing.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hematopoietic Stem Cell Transplant (HSCT) recipients * Age \>18 years * Status post bone marrow transplant within last five years Breast Cancer patients: Criteria 1 and Criteria 2 and/or 3 * Female age \>18 years and current or past history of breast cancer * Received systemic chemotherapy in the last five years * Metastatic breast cancer disease (stage IV) Lymphoma: Criteria 1 and Criteria 2 and/or 3 * Age \>18 years and current or past history of lymphoma * Received systemic chemotherapy within 5 years * Had active disease at any time within the last 5 years Exclusion Criteria: * Patients age\< 18 years * Breast cancer and lymphoma patients in clinical remission in the past 5 years * Patients unable to fill the questionnaire due to language barriers

What they're measuring

To determine the frequency of international travel of the targeted patients in the last 5 years.

Timeframe: once at the time of the clinic visit

Trial details

NCT IDNCT01111201

SponsorMemorial Sloan Kettering Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2012-03

View on ClinicalTrials.gov More Breast Cancer trials